Latest News | Concord Biotech Public Shareholder Sells Shares Worth Rs 483 Cr

New Delhi, May 28 (PTI) A public shareholder of pharmaceutical company Concord Biotech on Tuesday sold a 3.4 per cent stake in the company for Rs 483 crore through an open market transaction.

According to the bulk deal data available with the National Stock Exchange (NSE), 1575773 Ontario Inc offloaded 35,48,211 shares, amounting to a 3.4 per cent stake in Concord Biotech.

Also Read | Pandit Jawaharlal Nehru Death Anniversary 2024: Know Date, Significance About the Day That Marks the Punyatithi of India’s First Prime Minister.

The shares were disposed of at an average price of Rs 1,361.26 apiece, taking the deal value to Rs 483 crore.

After the stake sale, shareholding of 1575773 Ontario Inc in Concord Biotech has declined to 1.99 per cent from 5.39 per cent.

Also Read | Kendrapara Lok Sabha Elections 2024: BJP’s Baijayant Panda Takes on BJD’s Anshuman Mohanty, Congress’ Sidharth Swarup Das Amid Key Issues of Unemployment and Migration in This Constituency.

Meanwhile, Norges Bank, on account of the Government Pension Fund Global acquired 6 lakh shares or 0.57 per cent stake in Concord Biotech.

Details of the other buyers could not be ascertained.

On Tuesday, shares of Concord Biotech fell 2.41 per cent to close at Rs 1,406 apiece on the NSE. PTI HG

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)